PEG drugs: an overview
Top Cited Papers
- 1 July 2001
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 74 (1-3) , 159-171
- https://doi.org/10.1016/s0168-3659(01)00331-5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Detection and Characterization of Antibodies to PEG-IFN-alpha2b Using Surface Plasmon ResonanceJournal of Interferon & Cytokine Research, 1999
- Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal TissuesJapanese Journal of Cancer Research, 1998
- Design of Intramolecularly Activated ProdrugsDrug Metabolism Reviews, 1998
- Branched poly(ethylene glycol) linkersMacromolecular Chemistry and Physics, 1997
- PEG Thiazolidine-2-thione, a Novel Reagent for Facile Protein Modification: Conjugation of Bovine HemoglobinBioconjugate Chemistry, 1996
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal Of Cancer, 1995
- Highly water soluble taxol derivatives: 2′-polyethyleneglycol esters as potential prodrugsBioorganic & Medicinal Chemistry Letters, 1994
- Distribution and Tissue Uptake of Poly(ethylene glycol) with Different Molecular Weights after Intravenous Administration to MiceJournal of Pharmaceutical Sciences, 1994
- ProdrugsDrugs, 1985
- Alkaline Hydrolysis of Some Carbamic Acid Esters.Acta Chemica Scandinavica, 1964